Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.899
+0.011 (1.24%)
Nov 20, 2024, 4:00 PM EST - Market closed
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $36.17 million as of November 21, 2024. Its market cap has decreased by -81.24% in one year.
Market Cap
36.17M
Enterprise Value
-57.10M
1-Year Change
-81.24%
Ranking
Category
Stock Price
$0.90
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $36.17M, a decrease of -93.75%. That is a compound annual growth rate of -54.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 35.72M | -74.90% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Outset Medical | 37.71M |
| Lexaria Bioscience | 37.70M |
| Incannex Healthcare | 37.58M |
| NextCure | 37.49M |
| Lumos Pharma | 37.45M |
| Verrica Pharmaceuticals | 37.39M |
| Beyond Air | 36.81M |
| Carisma Therapeutics | 36.43M |